.BETA.-D-GLUCOPYRANOSIDURONIC ACID, 2-((7S,9AS)-7-((2,5-DIOXO-1-PYRROLIDINYL)METHYL)OCTAHYDRO-2H-PYRIDO(1,2-A)PYRAZIN-2-YL)-5-PYRIMIDINYL
UNII Q4J462G6Y9

Substance Identification & Data

This profile provides standardized clinical and technical data for .beta.-d-glucopyranosiduronic Acid, 2-((7s,9as)-7-((2,5-dioxo-1-pyrrolidinyl)methyl)octahydro-2h-pyrido(1,2-a)pyrazin-2-yl)-5-pyrimidinyl, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q4J462G6Y9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 200870-14-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q4J462G6Y9

CAS Registry Number

200870-14-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

.BETA.-D-GLUCOPYRANOSIDURONIC ACID, 2-((7S,9AS)-7-((2,5-DIOXO-1-PYRROLIDINYL)METHYL)OCTAHYDRO-2H-PYRIDO(1,2-A)PYRAZIN-2-YL)-5-PYRIMIDINYL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H31N5O9

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QPVDXQSMGMJLOM-NGODEQECSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

156028115

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1c(ncc(c1)O[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)C(=O)O)N3C[C@]4(N(CC3)C[C@H](CC4)CN5C(=O)CCC5=O)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for .beta.-d-glucopyranosiduronic Acid, 2-((7s,9as)-7-((2,5-dioxo-1-pyrrolidinyl)methyl)octahydro-2h-pyrido(1,2-a)pyrazin-2-yl)-5-pyrimidinyl. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.